GlassScriptPhysician profile
Joshua Alan Bell
NPI 1821402819
$3,449.89
in general payments reported to CMS, 2019-2025
7 companies · $446 in 2025
The $446 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,443 · 2020: $77.53 · 2021: $1,189 · 2022: $295 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.94 |
| Education | $208.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,575.63 | 2019-2025 | Persona |
| Stryker Corporation | $1,464.30 | 2019-2025 | Mako |
| Depuy Synthes Sales INC. | $166.82 | 2019-2022 | |
| Polynovo North America LLC | $154.88 | 2025 | Novosorb Btm |
| Medical Device Business Services, INC. | $47.00 | 2020 | |
| Viiv Healthcare Company | $22.05 | 2025 | |
| Heron Therapeutics, INC. | $19.21 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.